Approaches to Optimize Gene Therapy for the Treatment of Hematologic Malignancies: Overcoming the Obstacles

Author(s): Yingzhe Jiang, Bing Xia, Yizhuo Zhang*, Wen Xu

Journal Name: Current Gene Therapy

Volume 16 , Issue 6 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Gene transfer and oncolytic viruses provide new therapeutic approaches for the treatment of hematologic malignancies. However, it is still too early to introduce gene delivery or oncolytic viruses into standard clinical protocol. It is very important to discuss the obstacles that gene transfer and oncolytic virotherapy face for the further clinical application for the treatment of hematologic malignancies, and updating the advances made to overcome them. The major concerns in this review include the approaches of the development of immuno-stimulatory gene transfer mediated-vaccination for leukemia therapy, RNAi-based therapy for leukemia and enhancement of sensitivity of target malignant cells to virotherapy and alteration of host immune response to favor oncolytic viruses. We conclude with a perspective on the future of the gene therapy and virotherapy for the treatment of hematologic malignancies, emphasizing the problems we should solve and the technological requirements for further clinical applications.

Keywords: Gene transfer, vaccination, RNAi, oncolytic viruses, hematologic malignancies.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 14 March, 2017
Page: [390 - 400]
Pages: 11
DOI: 10.2174/1566523217666170215154755
Price: $65

Article Metrics

PDF: 33